Sabrina A. Assoumou, MD, MPH
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Infectious Diseases

MD, University of Rochester School of Medicine & Dentistry
MPH, Harvard School of Public Health




Sabrina A. Assoumou, MD MPH, is Assistant Professor of Medicine at Boston University School of Medicine and an attending physician in the section of Infectious Diseases at Boston Medical Center. She is a clinician-investigator who cares for human immunodeficiency virus (HIV)-infected patients at the BUSM/BMC’s Centers for Infectious Diseases. Her research focuses on medical complications of substance use including HIV and Hepatitis C virus (HCV). She is also interested in models of care and on improving the continuum of care for individuals with HIV and/or HCV. She is currently the Principal Investigator on an NIH K23 Mentored Career Development Award to improve linkage to care after testing for HIV and HCV at a drug detoxification center.

Dr. Assoumou has published in multiple journals including Clinical Infectious Diseases, AIDS, Annals of Internal Medicine and the Journal of American Medical Association. Her work has also been included in the American Association for the Study of Liver Diseases (AASLD)/ Infectious Diseases Society of America (IDSA) recommendations for testing, managing and treating HCV (Assoumou et al., Clin Infect Dis 2018) as well as HCV testing recommendations by the Centers for Disease Control and Prevention (Assoumou et al., Clin Infect Dis 2018 and Assoumou et al., Clin Infect Dis. 2019). Dr. Assoumou has also presented her findings at the National Academy of Sciences to the panel tasked with developing a National Strategy for the Elimination of Hepatitis B and C and at international scientific meetings such as IDWeek and the Conference on Retroviruses and Opportunistic Infections (CROI).

Dr. Assoumou graduated magna cum laude from Williams College and obtained her medical degree from the University of Rochester School of Medicine and Dentistry. She then completed a combined Internal Medicine/Pediatrics residency at Brown University and an Infectious Diseases Fellowship at Harvard University’s Beth Israel Deaconess Medical Center where she was awarded the Finland Award for Research Excellence. She also earned a Masters of Public Health at the Harvard T.H. Chan School of Public Health. Dr. Assoumou received an Excellence in Teaching Hospital-Based Faculty Award at BMC in 2017. She was also recognized as the Distinguished Faculty of the Month in April 2020 for her service to the BUSM community in teaching, service on committees, mentoring of students, trainees and junior faculty.

2020 Boston University School of Medicine: Distinguished Faculty of Month
2018 Boston University School of Medicine: Department of Medicine Career Investment Award
2017 Boston Medical Center: Excellence in Teaching Hospital-Based Faculty Award
2014-2017 National Institutes of Health: Loan Repayment Program
2011 Massachusetts Infectious Disease Society: Finland Award for Research Excellence
2004 University of Rochester School of Medicine and Dentistry: Bryce Collier Prize
2004 University of Rochester School of Medicine and Dentistry: Kenneth Woodward Memorial Award
2001 University of Rochester School of Medicine and Dentistry: International Medicine Fellowship
2000-2004 University of Rochester School of Medicine and Dentistry: Rochester Prize Scholarship
1995-1999 Williams College: Herbert Lehman Scholarship



Engaging Young People who Inject Drugs into HCV and HIV Care
05/01/2018 - 04/30/2023 (PI)
NIH-NIDA
1K23DA044085-01A1

Mentoring Early-Career Scientists for Drug Abuse Research Careers
05/01/2016 - 04/30/2018 (PI)
The Regents of the University of California NIH-NIDA


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Assoumou SA, Paniagua SM, Linas BP, Wang J, Samet JH, Hall J, White LF, Beckwith CG. Rapid Versus Laboratory-Based Testing for HIV and Hepatitis C at a Drug Detoxification Treatment Center: A Randomized Trial. J Infect Dis. 2020 Sep 02; 222(Supplement_5):S376-S383.View Related Profiles. PMID: 32877557
     
  2. Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Jul 25; 99:28-33.View Related Profiles. PMID: 32721528
     
  3. Assoumou SA, Nolen S, Hagan L, Wang J, Eftekhari Yazdi G, Thompson WW, Mayer KH, Puro J, Zhu L, Salomon JA, Linas BP. Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study. Am J Med. 2020 Jun 27.View Related Profiles. PMID: 32603791
     
  4. Assoumou SA, Tasillo A, Vellozzi C, Eftekhari Yazdi G, Wang J, Nolen S, Hagan L, Thompson W, Randall LM, Strick L, Salomon JA, Linas BP. Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in US Prisons. Clin Infect Dis. 2020 Mar 17; 70(7):1388-1396.View Related Profiles. PMID: 31095676
     
  5. Assoumou SA, Wang J, Nolen S, Eftekhari Yazdi G, Mayer KH, Puro J, Salomon JA, Linas BP. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic. J Gen Intern Med. 2020 May; 35(5):1477-1483.View Related Profiles. PMID: 32133577
     
  6. Epstein RL, Wang J, Hagan L, Mayer KH, Puro J, Linas BP, Assoumou SA. Hepatitis C Virus Antibody Testing Among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers. JAMA. 2019 12 10; 322(22):2245-2248.View Related Profiles. PMID: 31821424
     
  7. Childs E, Assoumou SA, Biello KB, Biancarelli DL, Drainoni ML, Edeza A, Salhaney P, Mimiaga MJ, Bazzi AR. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs. Harm Reduct J. 2019 02 11; 16(1):14.View Related Profiles. PMID: 30744628; DOI: 10.1186/s12954-019-0286-6;
     
  8. Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016. Am J Prev Med. 2019 01; 56(1):8-16.View Related Profiles. PMID: 30467088
     
  9. Assoumou SA, Tasillo A, Leff JA, Schackman BR, Drainoni ML, Horsburgh CR, Barry MA, Regis C, Kim AY, Marshall A, Saxena S, Smith PC, Linas BP. Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings. Clin Infect Dis. 2018 01 18; 66(3):376-384.View Related Profiles. PMID: 29020317
     
  10. Assoumou SA, Huang W, Young K, Horsburgh CR, Linas BP. Real-world Outcomes of Hepatitis C Treatment during the Interferon-free Era at an Urban Safety-net Hospital. J Health Care Poor Underserved. 2017; 28(4):1333-1344.View Related Profiles. PMID: 29176099
     
Showing 10 of 19 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 19 publications over 8 distinct years, with a maximum of 5 publications in 2020

YearPublications
20132
20144
20152
20161
20171
20182
20192
20205


Recent (within 3 months)

Students' Class-Delaying Partying Leaves Communities ‘Profoundly Disappointed'

NBC 10 9/14/2020

Coordinated Approach Needed to Increase Follow-Up Care After Rapid HIV, HCV Testing

Pharmacy Times 9/14/2020

HIV, Hep C Testing at Detox Centers Needs Strong Linkage-to-Care Effort

POZ 9/14/2020

Low test positivity rate key to getting kids back to school, doctor says

Boston 25 News 9/11/2020

Labor Day Could Become Coronavirus Superspreader as Millions Prepare to Travel

Newsweek 9/4/2020

With Indefinite Pause in Mass. Reopening, Businesses Describe ‘Dire Circumstances'

NECN 8/7/2020

Routine Hepatitis C Testing at FQHCs Would Be Cost-Effective

Drugs.com 7/22/2020

Cost-Effectiveness of Routine Hepatitis C Testing

MedicalResearch.com 7/10/2020

Routine Testing for Hepatitis C Can Cut Costs, Save Lives

Pharmacy Times 7/10/2020

Older

Coronavirus Threatens to Worsen Disparities, Distrust of Healthcare System Among Black Community

HealthCity 4/23/2020

Hep C Testing, Treatment Rates Low at Federally Qualified Health Centers

Drugs.com 3/13/2020

Hep C Testing, Treatment Rates Low at Federally Qualified Health Centers

Physicians Weekly 3/13/2020

A Gap in Diagnosis of Hepatitis C Infections During the Opioid Epidemic

HealthCity 3/4/2020

‘Test all, treat all’ cost-effective for HCV treatment in US prisons

Healio 5/30/2019

HCV Testing and Treatment in Prisons Improves Outcomes, But At What Price?

Contagion Live 5/30/2019

Risk-Based Testing Missed 35% Of HCV-Positive Prison Inmates

ID Practitioner 12/18/2018
Contact for Mentoring:

771 Albany St
Boston MA 02118
Google Map


Assoumou's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department